$70.45
-0.35 (-0.49%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-12.30%
1Y
+36.32%
YTD
-10.92%
Open$70.27
Previous Close$70.80
Day High$72.49
Day Low$70.20
52W High$99.50
52W Low$40.00
Volume—
Avg Volume549.0K
Market Cap2.70B
P/E Ratio—
EPS$-6.61
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$78.91
Below
SMA 200
$68.08
Above
RSI (14)
34.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
-68.1% upside
Current
$70.45
$70.45
Target
$22.47
$22.47
$15.33
$22.47 avg
$35.88
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.46B | 1.47B | 1.18B |
| Net Income | -261,677,643 | -297,076,371 | -250,070,353 |
| Profit Margin | -18.0% | -20.2% | -21.1% |
| EBITDA | -537,620,569 | -578,764,523 | -403,482,661 |
| Free Cash Flow | -321,004,356 | -279,609,663 | -183,137,834 |
| Rev Growth | +12.9% | +6.2% | -8.5% |
| Debt/Equity | 0.11 | 0.12 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |